NCT00334789View on ClinicalTrials.gov

Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

June 12, 2006

Primary Completion Date

March 29, 2018

Study Completion Date

March 29, 2018

Conditions
Adult Solid Neoplasm
Interventions
DRUG

Belinostat

Given IV

DRUG

Isotretinoin

Given orally

OTHER

Pharmacological Study

Correlative studies

Trial Locations (5)

15232

University of Pittsburgh Cancer Institute (UPCI), Pittsburgh

90033

USC / Norris Comprehensive Cancer Center, Los Angeles

91010

City of Hope Comprehensive Cancer Center, Duarte

91030

City of Hope South Pasadena, South Pasadena

95817

University of California Davis Comprehensive Cancer Center, Sacramento

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00334789 - Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery | Biotech Hunter | Biotech Hunter